https://m2.mtmt.hu/ eng 2026-09-21 14:49 JournalArticle 34754067 VALIDATED true Export Date: 8 April 2024 0 false 2026-02-23T12:17:41.780+0000 2025-07-30T16:36:34.901+0000 2024-03-25T07:58:25.751+0000 true 10069606 Pintér Ibolya Katalin /api/admin/10069606 Admin Ibolya Katalin Pintér (SE_AOK_TranszlációsMedInt_Admin5_PI, admin) true 2025-07-30T16:36:35.702+0000 2025-07-30T16:36:35.702+0000 2024-04-05T09:39:02.112+0000 true 10080205 Szalóky-Siki Ágnes /api/admin/10080205 Admin Ágnes Szalóky-Siki (SE_KK_Admin5_SZSA, admin) true true false true 24 24 /api/publicationtype/24 PublicationType Journal Article 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Journal Article 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Article (Journal Article) 101 true 10000059 true 1 /api/category/1 Category Scientific true 1 Szebeni, Janos true true /api/journal/1394737 REVIEWED METHODS IN MOLECULAR BIOLOGY 1064-3745 1940-6029 true false 1394737 true 1394737 true 1064-3745 1940-6029 Journal FOREIGN 2789 229 243 Chapter 23 229, Chapter 23 15 2024 Funding 2038404 /api/funding/2038404 (2020-1.1.6-JOVO-2021-00013) false true Funding 2038405 /api/funding/2038405 (2020-1.1.6-JÖVŐ-2021-00010) false true Funding 2038406 /api/funding/2038406 European Union Horizon 2020 projects(825828) false true Funding 2038407 /api/funding/2038407 European Union Horizon 2020 projects(952520) false true true true 2024 true true true false true false NONE 2026-02-23 false 1 0 1 0 1 1 1 1 1 1 1 0 0 0 1 0 1 0 1 0 0 20 20 Folyóiratcikk Journal Article 24 1 Könyvrészlet Chapter in Book 25 0 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2024 0 1 0 1 0 Q4 false 10003266 false false false 2024-04-04T09:39:01.698+0000 Nanomedicina Kutató és Oktató Központ (SE / AOK / I / KKI); Transzlációs Medicina Intézet (SE / AOK / I) 1 16 2 1 0 false Language 10002 /api/language/10002 English Angol English true 2 true PersonAuthorship 115907551 /api/authorship/115907551 Szebeni, Janos [Szebeni, János (Klinikai orvostud...), author] Nanomedicina Kutató és Oktató Központ (SU / FM / I / ICP); Transzlációs Medicina Intézet (SU / FM / I) 1 1.0 true false false Author 10003266 /api/author/10003266 János Szebeni (Klinikai orvostudomány, immunológia, nanomedicina) Szebeni János true 10003266 true Szebeni Janos true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PublicationIdentifier 25906143 /api/publicationidentifier/25906143 DOI: 10.1007/978-1-0716-3786-9_23 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true IDENTICAL 10.1007/978-1-0716-3786-9_23 https://doi.org/10.1007/978-1-0716-3786-9_23 false true PublicationIdentifier 25959441 /api/publicationidentifier/25959441 Scopus: 85188498522 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85188498522 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85188498522 true true PublicationIdentifier 25959443 /api/publicationidentifier/25959443 PubMed: 38507008 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 38507008 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=38507008&dopt=Abstract true true SjrRating 11466206 /api/sjrrating/11466206 sjr:Q4 (2024) Scopus - Genetics METHODS IN MOLECULAR BIOLOGY 1064-3745 1940-6029 283 1.0 book series RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 1311 /api/classificationexternal/1311 Scopus - Genetics true 1311 true Q4 DIRECT true true Reference 51326117 /api/reference/51326117 1. Szebeni J (2001) Complement activation-related pseudoallergy caused by liposomes, micellar carriers of intravenous drugs, and radiocontrast agents. Crit Rev Ther Drug Carrier Syst 18(6):567–606, DOI: 10.1615/CritRevTherDrugCarrierSyst.v18.i6.50 1 10.1615/CritRevTherDrugCarrierSyst.v18.i6.50 false true Reference 51326118 /api/reference/51326118 2. Szebeni J (2005) Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity. Toxicology 216(2–3):106–121, DOI: 10.1016/j.tox.2005.07.023 2 10.1016/j.tox.2005.07.023 false true Reference 51326119 /api/reference/51326119 3. Szebeni J (2014) Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals. Mol Immunol 61(2):163–173, DOI: 10.1016/j.molimm.2014.06.038 3 10.1016/j.molimm.2014.06.038 false true Reference 51326120 /api/reference/51326120 4. Barta BA, Radovits T, Dobos AB, Kozma GT, Meszaros T, Berenyi P, Facsko R, Fulop TG, Merkely B, Szebeni J (2023) The COVID-19 mRNA vaccine Comirnaty induces anaphylactic shock in an anti-PEG hyperimmune large animal model: role of complement activation in cardiovascular, hematological and inflammatory mediator changes. bioRxiv. https://doi.org/10.1101/2023.05.19.541479, DOI: 10.1101/2023.05.19.541479 4 10.1101/2023.05.19.541479 false true Reference 51326121 /api/reference/51326121 5. Dezsi L, Meszaros T, Kozma G, H-Velkei M, Olah CZ, Szabo M, Patko Z, Fulop T, Hennies M, Szebeni M, Barta BA, Merkely B, Radovits T, Szebeni J (2022) A naturally hypersensitive porcine model may help understand the mechanism of COVID-19 mRNA vaccine-induced rare (pseudo) allergic reactions: complement activation as a possible contributing factor. Geroscience 44(2):597–618, DOI: 10.1007/s11357-021-00495-y 5 10.1007/s11357-021-00495-y false true Reference 51326122 /api/reference/51326122 6. Szebeni J, Fontana JL, Wassef NM, Mongan PD, Morse DS, Dobbins DE, Stahl GL, Bunger R, Alving CR (1999) Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs – a model for pseudoallergic cardiopulmonary reactions to liposomes: role of complement and inhibition by soluble CR1 and anti-C5a antibody. Circulation 99(17):2302–2309, DOI: 10.1161/01.CIR.99.17.2302 6 10.1161/01.CIR.99.17.2302 false true Reference 51326123 /api/reference/51326123 7. Szebeni J, Fontana JL, Wassef NM, Mongan PD, Morse DS, Stahl GL, Bunger R, Alving CR (1998) Liposome induced and complement-mediated cardiopulmonary distress in pigs as a model of pseudo-allergic reactions to liposomal drugs. Mol Immunol 35(6–7):401–401, DOI: 10.1016/S0161-5890(98)90814-8 7 10.1016/S0161-5890(98)90814-8 false true Reference 51326124 /api/reference/51326124 8. Chanan-Khan A, Szebeni J, Savay S, Liebes L, Rafique NM, Alving CR, Muggia FM (2003) Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions. Ann Oncol 14(9):1430–1437, DOI: 10.1093/annonc/mdg374 8 10.1093/annonc/mdg374 false true Reference 51326125 /api/reference/51326125 9. Orfi E, Hricisak L, Dezsi L, Hamar P, Benyo Z, Szebeni J, Szenasi G (2022) The hypertensive effect of amphotericin B-containing liposomes (Abelcet) in mice: dissecting the roles of C3a and C5a anaphylatoxins, macrophages and thromboxane. Biomedicines 10(7):1764, DOI: 10.3390/biomedicines10071764 9 10.3390/biomedicines10071764 false true Reference 51326126 /api/reference/51326126 10. Szebeni J (2018) Mechanism of nanoparticle-induced hypersensitivity in pigs: complement or not complement? Drug Discov Today 23(3):487–492, DOI: 10.1016/j.drudis.2018.01.025 10 10.1016/j.drudis.2018.01.025 false true Reference 51326127 /api/reference/51326127 11. Szebeni J, Baranyi L, Savay S, Bodo M, Morse DS, Basta M, Stahl GL, Bunger R, Alving CR (2000) Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction. Am J Physiol Heart Circ Physiol 279(3):H1319–H1328, DOI: 10.1152/ajpheart.2000.279.3.H1319 11 10.1152/ajpheart.2000.279.3.H1319 false true Reference 51326128 /api/reference/51326128 12. Szebeni J, Bedocs P, Dezsi L, Urbanics R (2018) A porcine model of complement activation-related pseudoallergy to nano-pharmaceuticals: pros and cons of translation to a preclinical safety test. Precis Nanomed 1(1):63–73, DOI: 10.29016/180427.1 12 10.29016/180427.1 false true Reference 51326129 /api/reference/51326129 13. Urbanics R, Bedocs P, Szebeni J (2015) Lessons learned from the porcine CARPA model: constant and variable responses to different nanomedicines and administration protocols. Eur J Nanomed 7(3):219–231, DOI: 10.1515/ejnm-2015-0011 13 10.1515/ejnm-2015-0011 false true Reference 51326130 /api/reference/51326130 14. Szebeni J, Bawa R (2020) Human clinical relevance of the porcine model of pseudoallergic infusion reactions. Biomedicines 8(4):82, DOI: 10.3390/biomedicines8040082 14 10.3390/biomedicines8040082 false true Reference 51326131 /api/reference/51326131 15. Bedocs P, Capacchione J, Potts L, Chugani R, Weiszhar Z, Szebeni J, Buckenmaier CC (2014) Hypersensitivity reactions to intravenous lipid emulsion in swine: relevance for lipid resuscitation studies. Anesth Analg 119(5):1094–1101, DOI: 10.1213/ANE.0000000000000396 15 10.1213/ANE.0000000000000396 false true Reference 51326132 /api/reference/51326132 16. Bodo M, Szebeni J, Baranyi L, Savay S, Pearce FJ, Alving CR, Bunger R (2005) Cerebrovascular involvement in liposome – induced cardiopulmonary distress in pigs. J Liposome Res 15(1–2):3–14 16 false true Reference 51326133 /api/reference/51326133 17. Bodo M, Szebeni J, Baranyi L, Savay S, Pearce FJ, Alving CR, Bunger R (2005) Rheoencephalographic evidence of complement activation-related cerebrovascular changes in pigs. J Cereb Blood Flow Metab 25(1_suppl):S550, DOI: 10.1038/sj.jcbfm.9591524.0550 17 10.1038/sj.jcbfm.9591524.0550 false true Reference 51326134 /api/reference/51326134 18. Dezsi L, Fulop T, Meszaros T, Szenasi G, Urbanics R, Vazsonyi C, Orfi E, Rosivall L, Nemes R, Kok RJ, Metselaar JM, Storm G, Szebeni J (2014) Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: comparison of the porcine and rat responses. J Control Release 195:2–10, DOI: 10.1016/j.jconrel.2014.08.009 18 10.1016/j.jconrel.2014.08.009 false true Reference 51326135 /api/reference/51326135 19. Fulop T, Nemes R, Meszaros T, Urbanics R, Kok RJ, Jackman JA, Cho NJ, Storm G, Szebeni J (2018) Complement activation in vitro and reactogenicity of low-molecular weight dextran-coated SPIONs in the pig CARPA model: correlation with physicochemical features and clinical information. J Control Release 270:268–274, DOI: 10.1016/j.jconrel.2017.11.043 19 10.1016/j.jconrel.2017.11.043 false true Reference 51326136 /api/reference/51326136 20. Jackman JA, Meszaros T, Fulop T, Urbanics R, Szebeni J, Cho NJ (2016) Comparison of complement activation-related pseudoallergy in miniature and domestic pigs: foundation of a validatable immune toxicity model. Nanomedicine 12(4):933–943, DOI: 10.1016/j.nano.2015.12.377 20 10.1016/j.nano.2015.12.377 false true Reference 51326137 /api/reference/51326137 21. Merkel OM, Urbanics R, Bedocs P, Rozsnyay Z, Rosivall L, Toth M, Kissel T, Szebeni J (2011) In vitro and in vivo complement activation and related anaphylactic effects associated with polyethylenimine and polyethylenimine-graft-poly(ethylene glycol) block copolymers. Biomaterials 32(21):4936–4942, DOI: 10.1016/j.biomaterials.2011.03.035 21 10.1016/j.biomaterials.2011.03.035 false true Reference 51326138 /api/reference/51326138 22. Meszaros T, Kozma GT, Shimizu T, Miyahara K, Turjeman K, Ishida T, Barenholz Y, Urbanics R, Szebeni J (2018) Involvement of complement activation in the pulmonary vasoactivity of polystyrene nanoparticles in pigs: unique surface properties underlying alternative pathway activation and instant opsonization. Int J Nanomedicine 13:6345–6357, DOI: 10.2147/IJN.S161369 22 10.2147/IJN.S161369 false true Reference 51326139 /api/reference/51326139 23. Szebeni J, Baranyi L, Savay S, Bodo M, Milosevits J, Alving CR, Bunger R (2006) Complement activation-related cardiac anaphylaxis in pigs: role of C5a anaphylatoxin and adenosine in liposome-induced abnormalities in ECG and heart function. Am J Physiol-Heart C 290(3):H1050–H1058, DOI: 10.1152/ajpheart.00622.2005 23 10.1152/ajpheart.00622.2005 false true Reference 51326140 /api/reference/51326140 24. Szebeni J, Bedocs P, Csukas D, Rosivall L, Bunger R, Urbanics R (2012) A porcine model of complement-mediated infusion reactions to drug carrier nanosystems and other medicines. Adv Drug Deliver Rev 64(15):1706–1716, DOI: 10.1016/j.addr.2012.07.005 24 10.1016/j.addr.2012.07.005 false true Reference 51326141 /api/reference/51326141 25. Szebeni J, Bedocs P, Rozsnyay Z, Weiszhar Z, Urbanics R, Rosivall L, Cohen R, Garbuzenko O, Bathori G, Toth M, Bunger R, Barenholz Y (2012) Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome. Nanomedicine 8(2):176–184, DOI: 10.1016/j.nano.2011.06.003 25 10.1016/j.nano.2011.06.003 false true Reference 51326142 /api/reference/51326142 26. Szebeni J, Bedocs P, Urbanics R, Bunger R, Rosivall L, Toth M, Barenholz Y (2012) Prevention of infusion reactions to PEGylated liposomal doxorubicin via tachyphylaxis induction by placebo vesicles: a porcine model. J Control Release 160(2):382–387, DOI: 10.1016/j.jconrel.2012.02.029 26 10.1016/j.jconrel.2012.02.029 false true Reference 51326143 /api/reference/51326143 27. European Medicines Agency (2013) Reflection paper on the data requirements for intravenous liposomal products developed with reference to an innovator liposomal product, 21 Feb 2013 27 false true Reference 51326144 /api/reference/51326144 28. Milosevits G, Meszaros T, Orfi E, Bakos T, Garami M, Kovacs G, Dezsi L, Hamar P, Gyorffy B, Szabo A, Szenasi G, Szebeni J (2021) Complement-mediated hypersensitivity reactions to an amphotericin B-containing lipid complex (Abelcet) in pediatric patients and anesthetized rats: benefits of slow infusion. Nanomedicine 34:102366, DOI: 10.1016/j.nano.2021.102366 28 10.1016/j.nano.2021.102366 false true Reference 51326145 /api/reference/51326145 29. Wassef NM, Johnson SH, Graeber GM, Swartz GM Jr, Schultz CL, Hailey JR, Johnson AJ, Taylor DG, Ridgway RL, Alving CR (1989) Anaphylactoid reactions mediated by autoantibodies to cholesterol in miniature pigs. J Immunol 143(9):2990–2995, DOI: 10.4049/jimmunol.143.9.2990 29 10.4049/jimmunol.143.9.2990 false true Reference 51326146 /api/reference/51326146 30. Ostensen J, Hede R, Myreng Y, Ege T, Holtz E (1992) Intravenous injection of Albunex microspheres causes thromboxane mediated pulmonary hypertension in pigs, but not in monkeys or rabbits. Acta Physiol Scand 144(3):307–315, DOI: 10.1111/j.1748-1716.1992.tb09299.x 30 10.1111/j.1748-1716.1992.tb09299.x false true Reference 51326147 /api/reference/51326147 31. Walday P, Tolleshaug H, Gjoen T, Kindberg GM, Berg T, Skotland T, Holtz E (1994) Biodistributions of air-filled albumin microspheres in rats and pigs. Biochem J 299(Pt 2):437–443, DOI: 10.1042/bj2990437 31 10.1042/bj2990437 false true Reference 51326148 /api/reference/51326148 32. Szebeni J, Baranyi L, Savay S, Lutz HU, Jelezarova E, Bunger R, Alving CR (2000) The role of complement activation in hypersensitivity to pegylated liposomal doxorubicin (DOXIL (R)). J Liposome Res 10(4):467–481, DOI: 10.3109/08982100009031112 32 10.3109/08982100009031112 false true Reference 51326149 /api/reference/51326149 33. Kishimoto TK, Viswanathan K, Ganguly T, Elankumaran S, Smith S, Pelzer K, Lansing JC, Sriranganathan N, Zhao G, Galcheva-Gargova Z, Al-Hakim A, Bailey GS, Fraser B, Roy S, Rogers-Cotrone T, Buhse L, Whary M, Fox J, Nasr M, Dal Pan GJ, Shriver Z, Langer RS, Venkataraman G, Austen KF, Woodcock J, Sasisekharan R (2008) Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med 358(23):2457–2467, DOI: 10.1056/NEJMoa0803200 33 10.1056/NEJMoa0803200 false true Reference 51326150 /api/reference/51326150 34. Epstein-Barash H, Gutman D, Markovsky E, Mishan-Eisenberg G, Koroukhov N, Szebeni J, Golomb G (2010) Physicochemical parameters affecting liposomal bisphosphonates bioactivity for restenosis therapy: internalization, cell inhibition, activation of cytokines and complement, and mechanism of cell death. J Control Release 146(2):182–195, DOI: 10.1016/j.jconrel.2010.03.011 34 10.1016/j.jconrel.2010.03.011 false true Reference 51326151 /api/reference/51326151 35. Kuznetsova NR, Sevrin C, Lespineux D, Bovin NV, Vodovozova EL, Meszaros T, Szebeni J, Grandfils C (2012) Hemocompatibility of liposomes loaded with lipophilic prodrugs of methotrexate and melphalan in the lipid bilayer. J Control Release 160(2):394–400, DOI: 10.1016/j.jconrel.2011.12.010 35 10.1016/j.jconrel.2011.12.010 false true Reference 51326152 /api/reference/51326152 36. Sakai H, Suzuki Y, Sou K, Kano M (2012) Cardiopulmonary hemodynamic responses to the small injection of hemoglobin vesicles (artificial oxygen carriers) in miniature pigs. J Biomed Mater Res A 100(10):2668–2677, DOI: 10.1002/jbm.a.34208 36 10.1002/jbm.a.34208 false true Reference 51326153 /api/reference/51326153 37. Dezsi L, Szenasi G, Urbanics R, Rosivall L, Szebeni J (2013) Cardiopulmonary and hemodynamic changes in complement activation-related pseudoallergy. Health 5(6):1032–1038, DOI: 10.4236/health.2013.56138 37 10.4236/health.2013.56138 false true Reference 51326154 /api/reference/51326154 38. Le Lamer S, Paradis S, Rahmouni H, Chaimbault C, Michaud M, Culcasi M, Afxantidis J, Latreille M, Berna P, Berdeaux A, Pietri S, Morin D, Donazzolo Y, Abitbol JL, Pruss RM, Schaller S (2014) Translation of TRO40303 from myocardial infarction models to demonstration of safety and tolerance in a randomized Phase I trial. J Transl Med 12:38, DOI: 10.1186/1479-5876-12-38 38 10.1186/1479-5876-12-38 false true Reference 51326155 /api/reference/51326155 39. Dezsi L, Urbanics R, Meszaros T, Vazsonyi C, Fulop T, Orfi E, Rosivall L, Szebeni J, Szanasi G (2014) Cardiovascular manifestations of complement activation-related pseudoallergy following administration of liposomal nanomedicines. Acta Physiol 211:94–94 39 false true Reference 51326156 /api/reference/51326156 40. Csukas D, Urbanics R, Weber G, Rosivall L, Szebeni J (2015) Pulmonary intravascular macrophages: prime suspects as cellular mediators of porcine CARPA. Eur J Nanomed 7(1):27–36, DOI: 10.1515/ejnm-2015-0008 40 10.1515/ejnm-2015-0008 false true Reference 51326157 /api/reference/51326157 41. Barenholz Y, Szebeni J, Toth M, Rosivall L (2015) Particulate drug carriers as desensitizing agents. U.S. Patent 9,078,812 B2 41 false true Reference 51326158 /api/reference/51326158 42. Kasperovic P (2016) Dosages and methods for delivering lipid formulated nucleic acid molecules. US 2016/0122759 A1 42 false true Reference 51326159 /api/reference/51326159 43. Matuszak J, Baumgartner J, Zaloga J, Juenet M, da Silva AE, Franke D, Almer G, Texier I, Faivre D, Metselaar JM, Navarro FP, Chauvierre C, Prassl R, Dezsi L, Urbanics R, Alexiou C, Mangge H, Szebeni J, Letourneur D, Cicha I (2016) Nanoparticles for intravascular applications: physicochemical characterization and cytotoxicity testing. Nanomedicine 11(6):597–616, DOI: 10.2217/nnm.15.216 43 10.2217/nnm.15.216 false true Reference 51326160 /api/reference/51326160 44. Bugna S, Buscema M, Matviykiv S, Urbanics R, Weinberger A, Meszaros T, Szebeni J, Zumbuehl A, Saxer T, Muller B (2016) Surprising lack of liposome-induced complement activation by artificial 1,3-diamidophospholipids in vitro. Nanomed-Nanotechnol 12(3):845–849, DOI: 10.1016/j.nano.2015.12.364 44 10.1016/j.nano.2015.12.364 false true Reference 51326161 /api/reference/51326161 45. Buscema M, Matviykiv S, Meszaros T, Gerganova G, Weinberger A, Mettal U, Mueller D, Neuhaus F, Stalder E, Ishikawa T, Urbanics R, Saxer T, Pfohl T, Szebeni J, Zumbuehl A, Muller B (2017) Immunological response to nitroglycerin-loaded shear-responsive liposomes in vitro and in vivo. J Control Release 264:14–23, DOI: 10.1016/j.jconrel.2017.08.010 45 10.1016/j.jconrel.2017.08.010 false true Reference 51326162 /api/reference/51326162 46. Unterweger H, Janko C, Schwarz M, Dezsi L, Urbanics R, Matuszak J, Orfi E, Fulop T, Bauerle T, Szebeni J, Journe C, Boccaccini AR, Alexiou C, Lyer S, Cicha I (2017) Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging. Int J Nanomedicine 12:5223–5238, DOI: 10.2147/IJN.S138108 46 10.2147/IJN.S138108 false true Reference 51326163 /api/reference/51326163 47. Unterweger H, Dézsi L, Matuszak J, Janko C, Poettler M, Jordan J, Bäuerle T, Szebeni J, Fey T, Boccaccini AR, Alexiou C, Cicha I (2018) Dextran-coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging: evaluation of size-dependent imaging properties, storage stability and safety. Int J Nanomedicine 13:1899–1915, DOI: 10.2147/IJN.S156528 47 10.2147/IJN.S156528 false true Reference 51326164 /api/reference/51326164 48. Wibroe PP, Anselmo AC, Nilsson PH, Sarode A, Gupta V, Urbanics R, Szebeni J, Hunter AC, Mitragotri S, Mollnes TE, Moghimi SM (2017) Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes. Nat Nanotechnol 12(6):589–594, DOI: 10.1038/nnano.2017.47 48 10.1038/nnano.2017.47 false true Reference 51326165 /api/reference/51326165 49. Onwukwe C, Maisha N, Holland M, Varley M, Groynom R, Hickman D, Uppal N, Shoffstall A, Ustin J, Lavik E (2018) Engineering intravenously administered nanoparticles to reduce infusion reaction and stop bleeding in a large animal model of trauma. Bioconjug Chem 29(7):2436–2447, DOI: 10.1021/acs.bioconjchem.8b00335 49 10.1021/acs.bioconjchem.8b00335 false true Reference 51326166 /api/reference/51326166 50. Kozma GT, Meszaros T, Vashegyi I, Fulop T, Orfi E, Dezsi L, Rosivall L, Bavli Y, Urbanics R, Mollnes TE, Barenholz Y, Szebeni J (2019) Pseudo-anaphylaxis to polyethylene glycol (PEG)-coated liposomes: roles of anti-PEG IgM and complement activation in a porcine model of human infusion reactions. ACS Nano 13(8):9315–9324, DOI: 10.1021/acsnano.9b03942 50 10.1021/acsnano.9b03942 false true Reference 51326167 /api/reference/51326167 51. Piecha D, Dezsi L, Moore C, Petho A, Rosivall L, Canaud B, Szebeni J, Steppan S (2019) SP539 porcine CARPA model to study hypersensitivity-like reactions during dialysis. Nephrol Dial Transplant 34(Supplement 1):gfz103.SP539, DOI: 10.1093/ndt/gfz103.SP539 51 10.1093/ndt/gfz103.SP539 false true Reference 51326168 /api/reference/51326168 52. Fulop T, Kozma GT, Vashegyi I, Meszaros T, Rosivall L, Urbanics R, Storm G, Metselaar JM, Szebeni J (2019) Liposome-induced hypersensitivity reactions: risk reduction by design of safe infusion protocols in pigs. J Control Release 309:333–338, DOI: 10.1016/j.jconrel.2019.07.005 52 10.1016/j.jconrel.2019.07.005 false true Reference 51326169 /api/reference/51326169 53. Chauvierre C, Aid-Launais R, Aerts J, Chaubet F, Maire M, Chollet L, Rolland L, Bonafe R, Rossi S, Bussi S, Cabella C, Dezsi L, Fulop T, Szebeni J, Chahid Y, Zheng KH, Stroes ESG, Le Guludec D, Rouzet F, Letourneur D (2019) Pharmaceutical development and safety evaluation of a GMP-grade Fucoidan for molecular diagnosis of cardiovascular diseases. Mar Drugs 17(12):699, DOI: 10.3390/md17120699 53 10.3390/md17120699 false true Reference 51326170 /api/reference/51326170 54. Szebeni J (2020) Testing of drug-induced pseudo-allergies in a porcine model. World Allergy Organ J 13(8):100250, DOI: 10.1016/j.waojou.2020.100250 54 10.1016/j.waojou.2020.100250 false true Reference 51326171 /api/reference/51326171 55. Szebeni J, Kozma G, Meszaros T, Urbanics R (2020) Pseudo-anaphylaxis to PEGylated nanomedicines in a porcine model. World Allergy Organ J 13(8):100178, DOI: 10.1016/j.waojou.2020.100178 55 10.1016/j.waojou.2020.100178 false true Reference 51326172 /api/reference/51326172 56. Bedocs P, Szebeni J (2020) The critical choice of animal models in nanomedicine safety assessment: a lesson learned from hemoglobin-based oxygen carriers. Front Immunol 11:584966, DOI: 10.3389/fimmu.2020.584966 56 10.3389/fimmu.2020.584966 false true Reference 51326173 /api/reference/51326173 57. Petho A, Piecha D, Meszaros T, Urbanics R, Moore C, Canaud B, Rosivall L, Mollnes TE, Steppan S, Szenasi G, Szebeni J, Dezsi L (2021) A porcine model of hemodialyzer reactions: roles of complement activation and rinsing back of extracorporeal blood. Ren Fail 43(1):1609–1620, DOI: 10.1080/0886022X.2021.2007127 57 10.1080/0886022X.2021.2007127 false true Reference 51326174 /api/reference/51326174 58. Ke W, Chandler M, Cedrone E, Saito RF, Rangel MC, de Souza Junqueira M, Wang J, Shi D, Truong N, Richardson M, Rolband LA, Dreau D, Bedocs P, Chammas R, Dokholyan NV, Dobrovolskaia MA, Afonin KA (2022) Locking and unlocking thrombin function using immunoquiescent nucleic acid nanoparticles with regulated retention in vivo. Nano Lett 22(14):5961–5972, DOI: 10.1021/acs.nanolett.2c02019 58 10.1021/acs.nanolett.2c02019 false true Reference 51326175 /api/reference/51326175 59. Petho A, Szebeni J (2022) Pulmonary hypertension in a hemodialysis porcine model: possible unforeseen causes? Ren Fail 44(1):693, DOI: 10.1080/0886022X.2022.2064305 59 10.1080/0886022X.2022.2064305 false true Reference 51326176 /api/reference/51326176 60. Soliman KM, Rao V, Daoud A (2022) Pulmonary hypertension in a hemodialysis porcine model: possible unforeseen causes. Ren Fail 44(1):945–945, DOI: 10.1080/0886022X.2022.2045204 60 10.1080/0886022X.2022.2045204 false true Reference 51326177 /api/reference/51326177 61. Unterweger H, Janko C, Folk T, Cicha I, Kovacs N, Gyebnar G, Horvath I, Mathe D, Zheng KH, Coolen BF, Stroes E, Szebeni J, Alexiou C, Dezsi L, Lyer S (2023) Comparative in vitro and in vivo evaluation of different iron oxide-based contrast agents to promote clinical translation in compliance with patient safety. Int J Nanomedicine 18:2071–2086, DOI: 10.2147/IJN.S402320 61 10.2147/IJN.S402320 false true Reference 51326178 /api/reference/51326178 62. Kokeny G, Bakos T, Barta BA, Nagy GV, Meszaros T, Kozma GT, Szabo A, Szebeni J, Merkely B, Radovits T (2023) Zymosan particle-induced hemodynamic, cytokine and blood cell changes in pigs: an innate immune stimulation model with relevance to cytokine storm syndrome and severe COVID-19. Int J Mol Sci 24(2):1138, DOI: 10.3390/ijms24021138 62 10.3390/ijms24021138 false true /api/publication/34754067 Szebeni Janos. Evaluation of the Acute Anaphylactoid Reactogenicity of Nanoparticle-Containing Medicines and Vaccines Using the Porcine CARPA Model. (2024) METHODS IN MOLECULAR BIOLOGY 1064-3745 1940-6029 2789 229-243<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" mtid="10003266"><a href="/gui2/?type=authors&mode=browse&sel=10003266" target="_blank">Szebeni Janos (<span class="authorship-author-name">Szebeni János</span> <span class="authorAux-mtmt"> Klinikai orvostudomány, immunológia, nanomedicina</span>) </a> </span> <span class="author-affil"><span title="Semmelweis University">SU</span>/<span title="Faculty of Medicine">FM</span>/<span title="Instituties">I</span>/<span title="Transzlációs Medicina Intézet">TMI</span>/Nanomedicina Kutató és Oktató Központ; <span title="Semmelweis University">SU</span>/<span title="Faculty of Medicine">FM</span>/<span title="Instituties">I</span>/Transzlációs Medicina Intézet</span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;34754067" target="_blank">Evaluation of the Acute Anaphylactoid Reactogenicity of Nanoparticle-Containing Medicines and Vaccines Using the Porcine CARPA Model</a></div> <div> <span class="journal-title">METHODS IN MOLECULAR BIOLOGY</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/1064-3745">1064-3745</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1940-6029">1940-6029</a>)</span>: <span class="journal-volume">2789</span> <span class="page"> pp 229-243 Paper Chapter 23. </span> <span class="year">(2024)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Language: English | </span> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="10.1007/978-1-0716-3786-9_23" target="_blank" href="https://doi.org/10.1007/978-1-0716-3786-9_23"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85188498522" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85188498522"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="38507008" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=38507008&dopt=Abstract"> PubMed </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Journal subject: Scopus - Genetics&nbsp;&nbsp;&nbsp;Rank:&nbsp;Q4</div> <div class="journal-subject">Journal subject: Scopus - Molecular Biology&nbsp;&nbsp;&nbsp;Rank:&nbsp;Q4</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="" class="citingPub-count">Citing papers: 1</span> | Independent citation: 0 | Self citation: 1 | Unknown citation: 0 | Number of citations in WoS: 1 | Number of citations in Scopus:&nbsp;1 | WoS/Scopus assigned:&nbsp;1 | Number of citations with DOI:&nbsp;1 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;34754067&sort=publishedYear,desc&sort=title"> Number of cited publications: 20 </a> </div> <div class="mtid"><span class="long-pub-mtid">Publication: 34754067</span> | <span class="status-data status-VALIDATED"> Validated </span> Core Citing | <span class="type-subtype">Journal Article ( Article ) </span> | <span class="pub-category">Scientific</span> | <span class="publication-sourceOfData">kézi felvitel</span> </div> <div class="funder"> (2020-1.1.6-JOVO-2021-00013), (2020-1.1.6-JÖVŐ-2021-00010), European Union Horizon 2020 projects(825828), European Union Horizon 2020 projects(952520) </div> <div class="lastModified">Last Modified: 2025.07.30. 18:36 Lilian Vasvari (MTMT Központ, admin) </div> <pre class="comment" style="margin-top: 0; margin-bottom: 0;"><u>Comments</u>: Export Date: 8 April 2024</pre> </div></div>